Filters: Author is Goodman, Shaun G [Clear All Filters]
Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. N Engl J Med. 2012;367(14):1297-309.
Relation between previous angiotensin-converting enzyme inhibitor use and in-hospital outcomes in acute coronary syndromes. Am J Cardiol. 2012;109(3):332-6.
Use of Clopidogrel Post-Coronary Artery Bypass Surgery in Canadian Patients With Acute Coronary Syndromes. The Canadian journal of cardiology. 2011.
Temporal changes in the management and outcome of Canadian diabetic patients hospitalized for non-ST-elevation acute coronary syndromes. Am Heart J. 2011;162(2):347-355.e1.
Temporal trend of in-hospital major bleeding among patients with non ST-elevation acute coronary syndromes. Am Heart J. 2010;160(3):420-7.
Delay to reperfusion in patients with acute myocardial infarction presenting to acute care hospitals: an international perspective. Eur Heart J. 2010;31(11):1328-36.
Influence of age on use of cardiac catheterization and associated outcomes in patients with non-ST-elevation acute coronary syndromes. Am J Cardiol. 2009;103(11):1530-6.
Temporal trends and patterns of early clopidogrel use across the spectrum of acute coronary syndromes. Am Heart J. 2009;157(4):642-50.e1.
Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to go. European heart journal. 2008;29:609-17.
Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA : the journal of the American Medical Association. 2007;297:1892-900.
Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction? Circulation. 2007;116:2793-801.
Use of proven therapies in non-ST-elevation acute coronary syndromes according to evidence-based risk stratification. American heart journal. 2007;153:493-9.